Research programme: Hsp90 inhibitors - Kosan BiosciencesAlternative Names: KOS-2484
Latest Information Update: 01 Jul 2008
At a glance
- Originator Kosan Biosciences
- Class Benzoquinones; Macrocyclic lactams
- Mechanism of Action HSP90 heat-shock protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer